And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity
Cannabis Law Report
MARCH 2, 2020
First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). This landmark approval is unique in that ketamine is well known to have hallucinogenic properties, as well as a long history as a party drug. Potential IPOs within the next year.
Let's personalize your content